longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

002030

002030
5.502.14%( -0.12 )

LongbridgeAI

The hepatitis concept sector has seen a short-term surge

Zhitong
Jul 28, 2025 at 01:36 AM

The hepatitis concept sector saw a short-term surge, with KHB hitting the limit up, and C&Y Pharmaceutical, BIOCAUSE HEILEN PHARMA, DAJY, Yatai pharm, and Honz all rising

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Honz

Honz

SZ300086

-1.76%

KHB

KHB

SZ002022

-0.85%

C&Y Pharmaceutical

C&Y Pharmaceutical

SZ300254

-0.11%